Trodelvy

Sacituzumab Govitecan-Hziy

6.9 High risk

Trodelvy & Disease progression

26.5%

of users reported Disease progression

85.7%

also reported Severe reaction

100.0%

are women

Most common medical consequences

Severe reaction
85.7%
Death
7.8%
Disability
3.9%
Hospitalization
2.6%

Have you experienced any negative side effects from this medication?

Trodelvy: general information

Most common side effects (10)

Most commonly affected ages

30 - 39 years
9.8%
40 - 49 years
9.8%
50 - 59 years
52.9%
60 - 69 years
27.5%
On this page
Trodelvy & Disease progression
Trodelvy: general information